By expenditures
| Name | Title | Type |
|---|---|---|
| Mark Wall | CFO | Auditee |
| Brian Unsen | Partner | Auditee |
| Renee Gravalin | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 332039 | 2024 | 2024-12-11 | Eide Bailly LLP | $17.44M |
| 8319 | 2023 | 2023-12-22 | Eide Bailly LLP | $19.86M |
| 30839 | 2022 | 2023-03-12 | Eide Bailly LLP | $18.78M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 8319 | 2023 | 2023-12-22 | 582842 | 2023-005 | Significant Deficiency | Yes | ABL |
| 8319 | 2023 | 2023-12-22 | 582841 | 2023-004 | Significant Deficiency | Yes | AB |
| 8319 | 2023 | 2023-12-22 | 582840 | 2023-004 | Significant Deficiency | Yes | AB |
| 8319 | 2023 | 2023-12-22 | 582839 | 2023-004 | Significant Deficiency | Yes | AB |
| 8319 | 2023 | 2023-12-22 | 6400 | 2023-005 | Significant Deficiency | Yes | ABL |
| 8319 | 2023 | 2023-12-22 | 6399 | 2023-004 | Significant Deficiency | Yes | AB |
| 8319 | 2023 | 2023-12-22 | 6398 | 2023-004 | Significant Deficiency | Yes | AB |
| 8319 | 2023 | 2023-12-22 | 6397 | 2023-004 | Significant Deficiency | Yes | AB |
| 30839 | 2022 | 2023-03-12 | 613709 | 2022-005 | Material Weakness | Yes | ABL |
| 30839 | 2022 | 2023-03-12 | 613708 | 2022-004 | Material Weakness | Yes | P |
| 30839 | 2022 | 2023-03-12 | 613707 | 2022-004 | Material Weakness | Yes | P |
| 30839 | 2022 | 2023-03-12 | 37267 | 2022-005 | Material Weakness | Yes | ABL |
| 30839 | 2022 | 2023-03-12 | 37266 | 2022-004 | Material Weakness | Yes | P |
| 30839 | 2022 | 2023-03-12 | 37265 | 2022-004 | Material Weakness | Yes | P |